Antares Pharma Announces Pricing of Public Offering of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Antares Pharma Announces Pricing of Public Offering of Common Stock

EWING, N.J., May 6, 2015 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (Nasdaq: ATRS ) today announced that it has priced a firm commitment underwritten public offering of 20,000,000 shares of the Company's common stock at a purchase price to the public of $2.00 per share, resulting in net proceeds to the Company of $37.6 million (before estimated offering expenses payable by the Company). Piper Jaffray & Co. is acting as the sole book-running manager for the offering. Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. are acting as the co-managers of the offering. The offering is expected to close on or about May 11, 2015, subject to customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock.

The securities described above are being offered by Antares pursuant to a "shelf" registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC) on May 16, 2014. A prospectus supplement and an accompanying prospectus will be filed with the SEC in connection with the offering. Once filed, the prospectus supplement and accompanying prospectus may be obtained by sending a request to Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, by telephone at 800-747-3924, or by email at prospectus@pjc.com . Before you invest, you should read the prospectus supplement and accompanying prospectus, the registration statement, and the other documents that the Company has filed with the SEC for more complete information about the Company and this offering. Investors may obtain these documents for free by visiting the SEC's website at www.sec.gov .

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Antares Pharma

Antares Pharma focuses on self-administered parenteral pharmaceutical products. The Company's product, OTREXUP™ (methotrexate) injection for subcutaneous use, is approved in the U.S. for the treatment of adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis and adults with severe recalcitrant psoriasis. Antares Pharma is also developing QuickShot ® Testosterone for testosterone replacement therapy, and VIBEX ® Sumatriptan for the acute treatment of migraines. The Company's technology platforms include VIBEX ® disposable auto injectors, disposable multi-use pen injectors and reusable needle-free injectors. Antares Pharma has a multi-product deal with Teva Pharmaceutical Industries, Ltd.that includes VIBEX ® epinephrine, exenatide multi-dose pen, and another undisclosed multi-dose pen. Our reusable needle-free injector for use with human growth hormone (hGH) is sold worldwide by Ferring B.V. 

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements related to a public offering of the Company's common stock. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. These risks and uncertainties include, among others, changes in general market conditions and changes in the Company's revenue growth and difficulties or delays in the initiation, progress, or completion of the Company's product development plans. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''expect'', ''intend'', ''plan'', ''anticipate'', ''believe'', ''estimate'', ''predict'', ''potential'', ''seem'', ''seek'', ''future'', ''continue'', or ''appear'' or the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated by the forward-looking statements. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2014, and in the Company's other periodic reports and filings with the SEC. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law.

Jack Howarth Vice President, Corporate Affairs 609-359-3016

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ActivTrak's Fast 500 Rank Needs Investor Perspective

Updated Category News Views 60

Rank 488 is the sort of trophy that deserves a raised eyebrow, not confetti. ActivTrak made Deloitte's 2026 Technology Fast 500 after posting 101.1% revenue growth from 2022 through 2025, its sixth appearance on the list since 2020. That is real progress, and repeat recognition says this was not a one-quarter sugar high. Still, a Fast 500 ranking is a growth screen, not a...

Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand

Updated Category News Views 69

A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 85

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Valley Family Health Breach Notice Raises Hard Questions

Updated Category News Views 53

Seven months is a long time for sensitive patient data to sit inside an unresolved security story. Valley Family Health Care, Inc. says it suffered a network disruption on or about March 13, 2026, investigated with outside cybersecurity specialists, and ultimately determined that an unauthorized actor accessed and acquired certain files. The formal notification process...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 120

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 92

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 106

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
Vector Adds Mesa Division 10 Veteran for Arizona Growth

Updated Category News Views 94

A toilet-partition deal rarely raises eyebrows, but this one has the sturdy logic investors ought to notice. Vector Building Products has acquired Mesa-based Partitions & Accessories Co., a Division 10 specialist that has served Arizona contractors since 1978. It is not glamorous work. It is, however, the sort of necessary, specification-driven business that gets embedded...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 182

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Italian Wine Faces U.S. Slump and New Market Openings

Updated Category News Views 110

American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....

Continue Reading

Top 5 Most Recently Viewed Articles

MINISH Technology's Milestone: First U.S. Veneers Certification Success

Updated Category News Views 201

MINISH Technology Concludes First U.S. Veneers Course Health-tech company MINISH Technology Inc. has recently achieved a remarkable milestone by successfully completing its first MINISH Veneers course in the United States, certifying 22 dedicated dentists. This event highlights a significant step forward in the company’s commitment to advancing dental education and...

Continue Reading
Exciting Developments for Stellar V Capital Corp.'s Trading Options

Updated Category News Views 130

Stellar V Capital Corp. Announces Upcoming Trading Changes NEW YORK — Stellar V Capital Corp., a rising star in the acquisition space, has exciting news for its investors. Beginning March 24, 2025, holders of the units sold during the Company’s initial public offering will have the option to trade the Class A ordinary shares separately from the associated warrants....

Continue Reading
DelNorte’s Groundbreaking Data Tokenization Initiative Unveiled

Updated Category News Views 1405

Revolutionizing Public Data Management with DelNorte In an exciting move aimed at improving how public data is handled, DelNorte has partnered with a significant government body to initiate a cutting-edge data tokenization project. This initiative is centered around the introduction of the DTV Token, a vital component of DelNorte's innovative Terra Vision ecosystem,...

Continue Reading
Celebrating Success at the AMPLIFY A|E|C Conference

Updated Category News Views 67

WB Engineers+Consultants at the AMPLIFY A|E|C Conference Recently, WB Engineers+Consultants was proud to represent its ethos of innovation and excellence at the AMPLIFY A|E|C 2024 conference, a key event dedicated to the architecture, engineering, and construction (A/E/C) sectors. This distinguished conference was organized by the Society for Marketing Professional...

Continue Reading
Calix Faces Legal Fire Over Alleged Securities Missteps

Updated Category News Views 51

Calix Hits a Legal Snag: What's at Stake? In the gritty world of stock trading, nothing gets folks more riled up than talk of lawsuits—and here comes Calix, Inc. (NYSE: CALX) caught in a thorny one. Straight out of Los Angeles, the DJS Law Group beams a flare into the sky, reminding investors of a class action lawsuit tagged to violations of the Securities Exchange Act...

Continue Reading